The international breast cancer treatment consensus St. Gallen-2005: Departure to new risk selection and new treatment options

Breast

Volumn 14, Issue 6, 2005, Pages 427-428

  Senn, Hans Jörg ^a   Thürlimann, Beat ^a  

^a Tumor Center ZeTuP   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; LETROZOLE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RISK; CLINICAL TRIAL; CONSENSUS; EDITORIAL; HUMAN; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; SWITZERLAND;

EID: 28044472463     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.10.003     Document Type: Editorial

References (2)

1. A. Goldhirsch W.C. Wood R.D. Gelber A.S. Coates B. Thürlimann H.J. Senn Meeting highlights: Updated international expert consensus on the primary therapy of breast cancer J Clin Oncol 21 2003 3357-3365
2. A. Goldhirsch J.H. Glick R.D. Gelber A.S. Coates B. Thürliamnn H.J. Senn Panel Members Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 2005 1569-1583